emd 53998 has been researched along with ba 41899 in 11 studies
| Studies (emd 53998) | Trials (emd 53998) | Recent Studies (post-2010) (emd 53998) | Studies (ba 41899) | Trials (ba 41899) | Recent Studies (post-2010) (ba 41899) |
|---|---|---|---|---|---|
| 112 | 0 | 9 | 21 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuhrer, W; Herold, P; Herzig, JW; Leutert, T; Meier, M; Rihs, G; Schenker, K; Stutz, S; Wenk, P; Zbinden, P | 1 |
| Chiesi, M; Depersin, H; Grüninger, S; Hasenfuss, G; Herzig, JW; Holubarsch, C; Kubalek, R; Leutert, T; Pieske, B; Pioch, K; Wenk, P | 1 |
| Johnson, MD; Kitada, Y; Palmiter, KA; Solaro, RJ; Westfall, MV; Wolska, BM | 1 |
| Campbell, KB; Green, HW; Kirkpatrick, RD; Slinker, BK; Wu, Y | 2 |
| Arteaga, GM; Leiden, JM; Palmiter, KA; Solaro, RJ | 1 |
| Bloch, W; Brixius, K; Mehlhorn, U; Schwinger, RH | 1 |
| Egashira, K; Hayashidani, S; Ide, T; Kinugawa, S; Nakamura, R; Satoh, S; Suematsu, N; Takeshita, A; Tsutsui, H | 1 |
| Brixius, K; Hoischen, S; Lasek, K; Schwinger, RH; Zobel, C | 1 |
| Brixius, K; Reicke, S; Reuter, H; Schwinger, RH | 1 |
| Endoh, M | 1 |
1 review(s) available for emd 53998 and ba 41899
| Article | Year |
|---|---|
Cardiac Ca2+ signaling and Ca2+ sensitizers.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II; Animals; Azocines; Calcium; Calcium Signaling; Cardiotonic Agents; Cholinergic Agonists; Dihydropyridines; Endothelins; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyridazines; Quinolines; Simendan; Thiadiazines; Troponin C | 2008 |
10 other study(ies) available for emd 53998 and ba 41899
| Article | Year |
|---|---|
5-Methyl-6-phenyl-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazocine-2,4-dione (BA 41899): representative of a novel class of purely calcium-sensitizing agents.
Topics: Animals; Azocines; Calcium; Cardiotonic Agents; Electric Stimulation; Guinea Pigs; Heart Atria; Heart Failure; Imidazoles; In Vitro Techniques; Isometric Contraction; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Sensitivity and Specificity; Stereoisomerism; Swine | 1995 |
Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2
Topics: Aniline Compounds; Azocines; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Electric Stimulation; Humans; In Vitro Techniques; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Quinolines; Stimulation, Chemical; Thiadiazines; Xanthenes | 1996 |
CGP-48506 increases contractility of ventricular myocytes and myofilaments by effects on actin-myosin reaction.
Topics: Actin Cytoskeleton; Actins; Animals; Azocines; Calcium; Cardiotonic Agents; Diacetyl; Dogs; Dose-Response Relationship, Drug; Male; Myocardial Contraction; Myocardium; Myosins; Osmolar Concentration; Quinolines; Rats; Rats, Sprague-Dawley; Thiadiazines; Ventricular Function | 1996 |
Relaxation effect of CGP-48506, EMD-57033, and dobutamine in ejecting and isovolumically beating rabbit hearts.
Topics: Animals; Azocines; Cardiotonic Agents; Dobutamine; Heart; Heart Rate; In Vitro Techniques; Male; Mathematics; Models, Cardiovascular; Myocardial Contraction; Quinolines; Rabbits; Regression Analysis; Stroke Volume; Thiadiazines; Vasodilation | 1997 |
Overall cardiac functional effect of positive inotropic drugs with differing effects on relaxation.
Topics: Animals; Azocines; Calcium; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Rate; Male; Quinolines; Rabbits; Stroke Volume; Thiadiazines; Ventricular Function, Left | 2000 |
Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I.
Topics: Actin Cytoskeleton; Actins; Animals; Azocines; Calcium; Cardiotonic Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Mice; Mice, Transgenic; Muscle Contraction; Myocardium; Phosphodiesterase Inhibitors; Protein Isoforms; Quinolines; Sarcomeres; Thiadiazines; Troponin I | 2000 |
Different effect of the Ca(2+) sensitizers EMD 57033 and CGP 48506 on cross-bridge cycling in human myocardium.
Topics: Adult; Azocines; Calcium; Cardiotonic Agents; Diacetyl; Female; Humans; Male; Middle Aged; Myocardial Contraction; Quinolines; Thiadiazines; Troponin I | 2000 |
Positive inotropic effects of calcium sensitizers on normal and failing cardiac myocytes.
Topics: Animals; Azocines; Calcium; Cardiac Pacing, Artificial; Cardiotonic Agents; Dogs; Myocardial Contraction; Quinolines; Stimulation, Chemical; Thiadiazines; Ventricular Function, Left | 2001 |
[The Ca(2+) sensitizers CGP 48506 and EMD 57033, but not the Na(+) channel modulator BDF 9148, prolong relaxation in isolated cardiomyocytes of the guinea pig].
Topics: Animals; Azetidines; Azocines; Calcium Channels; Cardiotonic Agents; Cells, Cultured; Diastole; Dose-Response Relationship, Drug; Guinea Pigs; Male; Myocardial Contraction; Quinolines; Sodium Channels; Thiadiazines | 2001 |
Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium.
Topics: Azocines; Calcium; Calcium Channels; Cardiomyopathy, Dilated; Cardiotonic Agents; Culture Techniques; Cyclic AMP; Dose-Response Relationship, Drug; Heart Atria; Heart Ventricles; Humans; Myocardial Contraction; Quinolines; Thiadiazines | 2002 |